Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Pharmacol Ther ; 86(4): 378-82, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19606092

ABSTRACT

Oral melatonin (MEL) can improve daytime sleep, but the hormone's short elimination half-life limits its use as a hypnotic in shift workers and individuals with jet lag or other sleep problems. Here we show, in healthy subjects, that transdermal delivery of MEL during the daytime can elevate plasma MEL and reduce waking after sleep onset, by promoting sleep in the latter part of an 8-h sleep opportunity. Transdermal MEL may have advantages over fast-release oral MEL in improving sleep maintenance during adverse circadian phases.


Subject(s)
Central Nervous System Depressants/therapeutic use , Melatonin/therapeutic use , Sleep Disorders, Circadian Rhythm/drug therapy , Administration, Cutaneous , Adult , Body Temperature , Central Nervous System Depressants/administration & dosage , Circadian Rhythm/physiology , Cross-Over Studies , Delayed-Action Preparations , Double-Blind Method , Electroencephalography/drug effects , Female , Half-Life , Humans , Male , Melatonin/administration & dosage , Sex Factors , Sleep/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...